HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High

MT Newswires Live

2025/09/22

HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.

The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.

The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.

The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.

HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2569277498"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569277498\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569277498?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-22 11:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569277498","market":"hk","top_or_hot":-1,"title":"HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High","media":"MT Newswires Live","content":"<html><body><p> HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.</p><p>The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.</p><p>The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.</p><p>The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.</p><p>HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHeraMED Plans to Release Initial Version of AI-Powered Clinician Assistant in December Quarter; Shares Near Two-Year High\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-09-22 11:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.</p><p>The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.</p><p>The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.</p><p>The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.</p><p>HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7007","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569277498","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569277498","pubTimestamp":1758511669,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"HeraMED  will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7007":"医疗保健设备","HMD.AU":"HERAMED LTD"},"translate_title":"HeraMED计划在12月季度发布人工智能临床医生助理的初始版本；股价接近两年高点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HMD.AU":1},"content_text":"HeraMED (ASX:HMD) will accelerate the development of its artificial intelligence-powered Clinician Assistant, and the first version is expected to be released in the December quarter, which will include automated notes and workflow support, according to a Monday Australian bourse filing.The company also developed an ambient scribe tool, which uses AI to automatically generate structured consultation notes during virtual telehealth appointments.The medical technology company collaborated with the Digital Health Cooperative Research Centre and RMIT University to launch a project to develop AI predictive health models for high-risk pregnancies, including culturally and linguistically diverse populations.The firm decided to accelerate the development and deployment of its AI-driven technologies and product roadmap initiatives for the HeraCARE platform.HeraMED's shares rose nearly 3% in recent trading on Monday, hitting their highest since November 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}